Press "Enter" to skip to content

New patent expiration for Novo Nordisk drug NOVOLOG FLEXPEN


Annual Drug Patent Expirations for NOVOLOG+FLEXPEN
Annual Drug Patent Expirations for NOVOLOG+FLEXPEN

Novolog Flexpen is a drug marketed by Novo Nordisk Inc
and is included in one NDA. It is available from three suppliers. There are five patents protecting this drug.

This drug has seventy patent family members in twenty-two countries.

The generic ingredient in NOVOLOG FLEXPEN is insulin aspart recombinant. Three suppliers are listed for this compound. Additional details are available on the insulin aspart recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
or visit

Do NOT follow this link or you will be banned from the site!